Notas del episodio
In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Scott Brunner, CEO and President of the Alliance for Pharmacy Compounding, to examine how pharmacy compounding has shaped patient access during the GLP-1 shortage era. Rather than framing compounding as a workaround, Brunner explains how it operates within a rigorous, multilayered regulatory system involving the FDA, USP standards, and state boards of pharmacy.
Together, they discuss how drug makers have sometimes conflated legitimate compounding with counterfeit activity, the growing black market for unapproved peptides, and…
Web: shows.acast.com

